Immediate Impact
2 by Nobel laureates 71 standout
Citing Papers
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
2024 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
Works of Romil Chadha being referenced
The combination of bevacizumab (B) and erlotinib (E) shows significant biological activity in patients with advanced hepatocellular carcinoma (HCC)
2007
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Romil Chadha | 71 | 151 | 101 | 386 | 228 | 15 | 620 | |
| Raxitkumar Jinjuvadia | 71 | 80 | 105 | 210 | 149 | 24 | 579 | |
| Touraj Mansourbakht | 110 | 260 | 90 | 221 | 117 | 14 | 615 | |
| Xiaoping Wu | 219 | 90 | 79 | 327 | 179 | 28 | 691 | |
| Takeo Kimoto | 300 | 128 | 112 | 424 | 79 | 27 | 712 | |
| Yu Wen | 111 | 155 | 106 | 161 | 40 | 17 | 564 | |
| Hong Zhu | 84 | 291 | 148 | 321 | 125 | 27 | 620 | |
| Kian Fong Foo | 189 | 311 | 232 | 127 | 75 | 24 | 694 | |
| Donald Poon | 103 | 222 | 130 | 242 | 171 | 19 | 681 | |
| Yasuhide Motoyoshi | 49 | 134 | 36 | 303 | 49 | 27 | 607 | |
| Penglei Ge | 91 | 203 | 187 | 162 | 73 | 17 | 574 |
All Works
Loading papers...